People · Operator
Named in public records as an officer, director or promoter · active 2015–2015 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| C4 Therapeutics, Inc. | — | Biotechnology | Series C | $70.3M | $2.9B | 2015 |
Kenneth M. Anderson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kenneth M. Anderson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Marc Cohen | 1 | 6 |
| Jason Fisherman | 1 | 5 |
| Jay M. Eastman | 1 | 4 |
| Ronald W. Kaiser | 1 | 2 |
| William M. Scalzulli | 1 | 1 |
| Malcolm S. Salter | 1 | 1 |
| Bruce M. Downey | 1 | 1 |
| Alain Cohen | 1 | 1 |
| Elena M. Prokupets | 1 | 1 |
| Bihua M. Chen | 1 | 1 |
| Miles M. Stuchin | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.